MBG453 in Lower Risk MDS

Clinical trial NCT04823624 · TERMINATED

Trial details

NCT number: NCT04823624
Sponsor: Massachusetts General Hospital
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndromes

Start date: 2022-01-27
Primary completion: 2024-11-12
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.